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Multifocal renal cell carcinoma (RCC) has been reported in 5–25% of cases worldwide.
Although management of patients with multifocal RCC has not been clearly deﬁned, pres-
ence of multifocal renal masses in one kidney and a normal contralateral kidney has often
been considered a reason for performing radical nephrectomy.This study reviews theworld
literature to provide an accurate estimate of the prevalence of multifocal RCC and evalu-
ates the oncologic outcomes of multifocal RCC after exclusion of patients with known
hereditary and familial renal syndromes. A PubMed search of the literature was performed
for articles in the English language using the following terms for the query: “multifocal
RCC,” “multifocality and RCC,” “multicentric RCC,” or “bilateral RCC.” The references of
the published articles were also reviewed for additional publications. Articles that did not
speciﬁcally exclude patients with familial RCC or known hereditary RCC syndromes were
excluded for estimation of multifocality prevalence and oncologic outcomes. After apply-
ing our exclusion criteria, nine articles were selected and form the basis of the current
analysis. Weighted averages were used to calculate the prevalence of multifocality. Mul-
tifocal RCC was found in 6.8% of cases (373 of 5433 patients). Ipsilateral multifocality
was found in 6.8% of cases. Bilateral multifocality was found in 11.7% of cases. Of all
cases reported in this study, only 10% underwent partial nephrectomy. The rest of the
study cohort underwent radical nephrectomy. The review of the literature showed that
the use of nephron-sparing techniques in patients with multifocal disease did not compro-
mise oncologic outcomes, despite the need for reoperation in certain cases. In conclusion,
multifocal RCC remains a prevalent entity. Most clinicians still prefer to perform radical
nephrectomies in these patients despite proven equivalent oncologic outcomes compared
to nephron-sparing techniques. Urologists should be aware of these data when proposing
treatment options to patients with multifocal RCC.
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INTRODUCTION
Identifying patients with multifocal renal cell carcinoma (RCC) is
of major importance due to its inﬂuence on the treatment strategy,
timing, and treatment modality used in such patients. Manage-
ment of multifocal RCC has been a source of multiple debates
for several reasons. First of all, it remains one of the relative con-
traindications to partial nephrectomy (Campbell et al., 2007) as
it causes many urologists to think twice before embarking on a
nephron-sparing approach, either due to technical considerations
or oncologic concerns (Vogelzang, 2006). Second, radical nephrec-
tomy would prevent the patient from potentially requiring a future
repeat renal surgery for new or recurrent lesions in the same renal
unit; a procedure known to be technically challenging. Third, in
the absence of speciﬁc genetic studies to identify the clonal origin
of every lesion, some may feel uncomfortable assigning ipsilateral
or contralateral recurrences as de novo satellite tumors rather than
intra-renalmetastases. Finally, the relative paucity of reported out-
comes for patients treated for multifocal RCC has not allowed for a
wide acceptance of the nephron-sparing approaches as a preferred
treatment modality.
Multifocal RCC has been reported in 5–25% of cases in the
world literature (Kinouchi et al., 1999; Wunderlich et al., 1999).
This incongruent variability in values is likely due to a variety of
reasons. First, some of those studies have not excluded all patients
with hereditary or familial RCC, known to be multifocal in nature
(Delakas et al., 2002; Klatte et al., 2007; Linehan et al., 2009; Sargin
et al., 2009). Second the quality of imaging modalities as well as
radiologic evaluation used in different eras or locations may have
contributed to the variability in detection of multifocal RCC found
by different groups (Schlichter et al., 2000). Third, the pathological
assessment of specimens has also varied in the different reports.
Some investigators examined the renal surface only, others exam-
ined the kidney after stripping its capsule, while others examined
the kidneys after they had been serially sectioned. Finally, the
absence of accepted criteria used to deﬁne multifocality may have
also resulted in variations of the estimated prevalence of multifocal
RCC in the literature.
In the present report, we aim to examine differences in mul-
tifocality deﬁnitions and detection strategies used in published
studies to identify the prevalence of “sporadic” multifocal RCC.
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We also examine oncologic outcomes of surgeries for sporadic
multifocal RCC.
METHODS
SYSTEMATIC REVIEW OF THE LITERATURE
A PubMed search of the literature was performed independently
by each author for articles in the English language using the
following terms for the query: “multifocal RCC,” “multifocality
and RCC,”“multicentric RCC,” or “bilateral RCC.” The references
of the published articles were also reviewed for additional pub-
lications. We excluded articles that did not speciﬁcally exclude
patients with familial RCC or known hereditary renal cancer syn-
dromes, and those articles in which the prevalence for multifocal
RCC could not be determined. After applying our exclusion crite-
ria, nine articles were selected and these form the basis for the
current analysis. The oncologic outcomes were then tabulated
from the articles that met our inclusion criteria. Inclusion and
exclusion criteria were decided before the literature search was
initiated.
For the purpose of this study, multifocality was deﬁned as the
presence of two or more tumors present in the same renal unit,
regardless of histology or timing of detection in the absence of
extra-renal metastatic disease. The prevalence of multifocal RCC
was calculated using weighted averages after dividing the number
of cases with multifocality by the number of total cases with RCC
(solitary and multifocal RCC).
RESULTS
The prevalence of non-hereditary sporadic multifocal RCC was
calculated to be 6.8% (Table 1). The occurrence of bilateral mul-
tifocal tumors was found to be 11.7%. As shown in Table 2,
a subset analysis of our cohort shows that metastasis-free sur-
vival and overall-survival are similar to those reported by other
series (Table 3). Furthermore, oncologic outcomes are similar for
patients treated for solitary as well as for multifocal tumors (in
sporadic population). Finally, Table 3 shows excellent renal func-
tional preservation in the setting of multiple surgeries on the same
renal unit (in hereditary population).
Table 1 | List of peer reviewed articles included for analysis.
Reference Serial Total Total multifocal RN (%) PN (%) Ipsilateral Bilateral
section? cases multifocal (%) multifocal (%)
Tsivian et al. (2010) Yes 560 81 (14.4%) 560 0 81 (14.4%) n/a
Crispen et al. (2008b) n/a 1113 60 (5.4%) 599 (53.8%) 514 (46.2%) 60 (5.4%) 8/37 (21%)
Krambeck et al. (2008) n/a 140 n/a 114 (81.4%) 26 (19.6%) n/a 11 (7.85%)
Richstone et al. (2004) Yes 1071 57 (5.3%) 1071 0 57 (5.3%) 28 (2.6%)
Dimarco et al. (2004) n/a 2373 130 (5.4%) 2373 0 130 (5.4%) n/a
Bilen et al. (1999) Yes 40 4 (10%) 40 0 4 (10%) n/a
Kinouchi et al. (1999) Yes 124 23 (18.5%) 124 0 23 (18.5%) n/a
Oya et al. (1995) Yes 108 7 (6.5%) 108 0 7 (6.5%) n/a
Whang et al. (1995) Yes 44 11 (25%) 44 0 11 (6.5%) n/a
Weighted average: Weighted average: Weighted average:
6.82% 6.82% 11.72%
Table 2 | Oncologic outcomes for the study cohort.
Reference Number Number of Median Metastasis-free Cancer-specific Overall-survival Contralateral
of cases multifocal follow-up survival at survival at at 5 years (%) tumor-free survival
kidneys (year) 5 years (%) 5 years (%) at 5 years (%)
Solitary Multifocal Solitary Multifocal Solitary Multifocal Solitary Multifocal
tumors tumors tumors tumors tumors tumors tumors tumors
Crispen et al. (2008b) 1113 60 6.1 97.6 96.5 98.7 96.2 84.4 84 99.1 94.4
Krambeck et al. (2008) 140 140 6.1 n/a n/a n/a 90.5 (95.8 n/a n/a n/a n/a
if NSS)*
Richstone et al. (2004) 1071 57 3.4 73.2 71.5 n/a n/a 79.3 75.2 84.9 82.5
n/a, not available.
*CCS at 5 years for cases treated with radical nephrectomy or nephron-sparing surgery are 90.5 and 95.8%, respectively.
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Table 3 | Functional outcomes post-nephron-sparing techniques in
hereditary multifocal RCC.
Reference Number
of cases
Median follow-
up (month)
Change in serum
creatinine (mg/dl)
Bratslavsky et al. (2008) 13 25 +0.2
Johnson et al. (2008) 51 56 +0.19
Herring et al. (2001) 62 30 +0.01
Liu et al. (2010) 25 60 +0.2
DISCUSSION
We found that the prevalence of sporadic multifocal RCC was
6.8% (Table 1). This number is intriguing as the 6.8% rate of
multifocality found in this study correlates well with the his-
toric incidence of ipsilateral recurrence after partial nephrectomy
of 4–9% (Kinouchi et al., 1999; Crispen et al., 2008a; Peycelon
et al., 2009). This appears to suggest that many of the lesions
that have been considered recurrences or intra-renal metasta-
sis in the past might have just been incipient multifocal lesions
not identiﬁed pre-operatively or during the actual surgical pro-
cedure. Notably, many studies have shown that most satellite
lesions, in excess of 60%, are not detected by modern pre-
operative imaging studies (Baltaci et al., 2000; Crispen et al., 2008b;
Krambeck et al., 2008).
DEFINING MULTIFOCAL RCC
One of the major problems in the study of multifocal RCC is pre-
cisely how to deﬁne multifocality itself. What deﬁnes a multifocal
tumor? Is it simply the presence of another lesion within the same
renal unit (Miyake et al., 1998; Junker et al., 2002)? Must the sec-
ond lesion by necessity be malignant? Must there be a minimum
amount of parenchyma in between primary and satellite lesions
in order for multifocality to exist (Sargin et al., 2009)? Must all
lesions share the same histology? Does the presence of a contralat-
eral tumor also deﬁne multifocal disease (Bani-Hani et al., 2005)?
Does the contralateral kidney need to contain multiple tumors for
it to be multifocal? And is the multifocality on one kidney related
to the multifocality on the opposite kidney? Furthermore, how
can we even know if a second lesion within the same renal unit, or
on the contralateral kidney for that matter, is a new de novo lesion
unrelated to the primary tumor, or a local recurrence or metastasis
from the primary lesion?
Unfortunately, without performing a speciﬁc genetic study
designed to evaluate the clonal origin of each mass found it
is often difﬁcult to determine whether a second renal lesion
implies that patients have multifocal, recurrent, or metastatic dis-
ease (Miyake et al., 1998; Junker et al., 2002; Blute et al., 2003).
Because of our inability to answer these questions, in the present
study, we deﬁned multifocality in a broad manner in order to
incorporate all the data available to us. Thus, we deﬁned mul-
tifocality as the presence of two or more tumors present in
the same renal, regardless of histology or timing of detection,
in the absence of extra-renal metastatic disease in patients not
known to have familial disease or hereditary syndromes. We
acknowledge that some patients in our study may nevertheless be
part of obscure or yet-to-be-discovered RCC syndromes. This is
because the diagnosis of hereditary or familial RCC is not always
straight forward and while certain syndromes are well know to
all urologists, others, such as familial renal syndromes seen in
patients with tuberous sclerosis or succinate dehydrogenase deﬁ-
ciency, for example, are not. In terms of histology, from our
earlier studies of hereditary renal tumors we know that multi-
ple tumors of various histologies can coexist within the same
renal unit. We also know that the same genetic abnormality
can lead to both benign and malignant renal lesions within the
same kidney and that these lesions can also be found bilaterally
and metachronously. For example, patients with von Hippel–
Lindau (VHL) syndrome are prone to develop bilateral multifocal
recurrent clear cell RCC; patients with hereditary papillary RCC
(HPRCC) develop bilateral papillary type 1 RCC; hereditary
leiomyomatosis RCC (HLRCC) patients tend to form aggressive
papillary type 2 RCC and Birt–Hogg–Dubé (BHD) patients may
develop a whole spectrum of tumors from benign oncocytomas
to chromophobe RCC to aggressive clear cell RCC (Toro et al.,
2008). Furthermore, as our knowledge of the genetic basis of renal
neoplasias grows we keep ﬁnding new types of hereditary syn-
dromes, such as the less well understood syndromes of tuberous
sclerosis and succinate dehydrogenaseBdeﬁciency (Sudarshan and
Linehan, 2006).
HISTORICAL PERSPECTIVE AND CURRENT APPROACH
TO MULTIFOCAL RCC
Ever since Robson’s 1969 article (Robson et al., 1969) suggested
that radical nephrectomy should be the treatment of choice for
patients with renal tumors, that practice has become standard
of care, in particular for kidneys harboring multifocal RCC. Of
note, Robson et al.’s (1969) conclusion was based on a report
of outcomes of a few selected patients. During the next 30–
40 years, in large part due to the knowledge gained through
patients who underwent partial nephrectomies for imperative
indications, Robson’s model has come under question. Initial
reports about the technical feasibility of nephron-sparing pro-
cedures performed for small renal masses and subsequent reports
of its oncologic efﬁcacy, similar to that of radical nephrectomy,
have slowly built a foundation for a wider utilization of partial
nephrectomy (Russo et al., 2002). Additionally, with the under-
standing that RCC was not a single entity but a conglomeration
of neoplastic processes, each with its own biological identity
and aggressiveness (Kovacs et al., 1997), the ﬁeld of urology
has slowly realized that perhaps a one-operation-ﬁts-all model
was not the best way to approach every type of renal tumor.
Thus, the indications for elective partial nephrectomy began to
expand (Russo et al., 2002), resulting in a much larger cohort
of cases to be analyzed and compared to outcomes of radical
nephrectomy.
We now know that, despite previous teachings, not only tumors
smaller than 4 cm but also larger than 4 cm are amenable
to nephron-sparing techniques (Russo, 2007). We also know
that stage-by-stage the oncologic outcomes seem to be similar
between partial nephrectomy and radical nephrectomy cohorts
(Bratslavsky et al., 2008; Johnson et al., 2008; Breau et al., 2010;
Liu et al., 2010). Furthermore, recent data have conﬁrmed
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that patients undergoing radical nephrectomies for RCC are at
higher risk not only of developing renal insufﬁciency (Huang
et al., 2006; Sorbellini et al., 2006) but more ominously, to
die of non-cancer-related causes, such as cardiovascular events,
compared to patients undergoing nephron-sparing techniques
(Huang et al., 2009). Additionally, data from patients treated
with multiple partial nephrectomies for hereditary and famil-
ial RCC syndromes indicate that the oncologic outcome is
not altered in those patients when they undergo multiple
repeated partial nephrectomies (Gupta et al., 2010). Finally,
National Cancer Institute data on repeat surgical interventions
on a same kidney indicate that kidneys can withstand multiple
injuries due to surgical procedures and renal function is usu-
ally well-preserved (Table 3), preventing patients from having to
undergo dialysis or renal transplantation (Bratslavsky et al., 2008;
Gupta et al., 2010).
Despite all this information, indications for partial nephrec-
tomy still need to be enumerated and radical nephrectomies
are still favored by a large number of urologists even for small
solitary renal tumors of less than 4 cm in maximum diam-
eter (Russo, 2006). In fact, at the present time there are no
NCCN Guidelines regarding multifocal RCC tumors. Perhaps a
better treatment approach for sporadic multifocal RCC would
be performing the same type of surgery as for patients with
familial or hereditary RCC syndromes, i.e., resection of all
detectable renal lesions via nephron-sparing techniques as they
become apparent and reach a certain size (Walther et al., 1999).
The latter is supported by the fact that: (a) there is no onco-
logic beneﬁt to performing radical nephrectomy versus partial
nephrectomy, (b) there are no data proving that newly discov-
ered post-surgical lesions are indeed recurrences or metastases
after partial nephrectomy, (c) at least 20% of RCC lesions are
either benign or indolent in nature, and (d) the data showing
that losing a renal unit puts patients at higher risk not only
of developing renal insufﬁciency but also of death from non-
cancer-related causes (Crispen et al., 2008a). Finally, as the data
presented in this study show, a signiﬁcant number of patients
with multifocal RCC will have renal lesions in the contralateral
kidney, possibly necessitating surgery at a later date, increasing
their chances of becoming anephric, had radical nephrectomy
previously performed.
CLINICAL IMPLICATIONS
Identifying patients at higher risk for metastatic disease and those
who are likely to fail local therapy is indeed of paramount impor-
tance. Nevertheless, treating patients with overkill surgeries under
the presumption that more is better puts patients at risk not
only for renal insufﬁciency but also for cardiovascular disease
and death from non-cancer-related causes (Sorbellini et al., 2006;
Huang et al., 2009). Radical nephrectomy may not only be unnec-
essary in these patients but it may also prevent those patients from
future treatments (e.g., targeted therapies) that require a normal
renal function to qualify for them. Although we strongly advocate
appropriate surgery for local control of renal lesions, with negative
surgical margins, the reader should also be aware of recent data
showing that positive surgical margins do not jeopardize survival
outcomes in patients undergoing nephron-sparing techniques
(Yossepowitch et al., 2008). Therefore, we encourage surgeons
to attempt nephron-sparing surgery whenever technically feasible
and, in cases of multifocal disease.
LIMITATIONS OF THE STUDY
The present study has several limitations. It is possible that some of
the patients included in our analysis were undiagnosed hereditary
RCC cases. We only reported results on patients treated surgically
and may have potentially missed those with metastatic disease that
were not included in the original publications.
CONCLUSION
Multifocal RCC remains an underappreciated and misunderstood
entity with a prevalence of at least 6%. Bilateral multifocal dis-
ease is found in 11.7% of cases. The presence of multiple renal
tumors in one kidney appears to increase the risk of having renal
lesions in the contralateral kidney. Twenty percent of multifocal
RCC are benign or indolent in nature. Stage-by-stage, oncologic
outcome appears similar for patients treated with radical or partial
nephrectomy. Resection of multiple renal lesions from the same
renal unit in a single setting is feasible and may allow for excellent
preservation renal function. Radical nephrectomy, in the context
of RCC, appears to increase the risk of renal insufﬁciency and
death from unrelated causes. Nephron-sparing techniques should
thus be considered whenever technically feasible, in particular in
cases of multifocal RCC.
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